Itraconazole: a reappraisal of its pharmacological properties and therapeutic use in the management of superficial fungal infections
M Haria, HM Bryson, KL Goa - Drugs, 1996 - Springer
Synopsis Itraconazole is an orally administered triazole antifungal agent Its spectrum of
activity includes dermatophyte, dimorphic and dematiaceous fungi, yeasts, and some …
activity includes dermatophyte, dimorphic and dematiaceous fungi, yeasts, and some …
Itraconazole
GE Piérard, JE Arrese… - Expert opinion on …, 2000 - Taylor & Francis
Itraconazole is a broad spectrum triazole antifungal agent. It has favourable
pharmacodynamic and pharmacokinetic profiles and is available as both oral and iv …
pharmacodynamic and pharmacokinetic profiles and is available as both oral and iv …
Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris: a randomized …
Importance With worldwide emergence of recalcitrant and resistant dermatophytosis,
itraconazole is increasingly being used as the first-line drug for treatment of tinea …
itraconazole is increasingly being used as the first-line drug for treatment of tinea …
Indian association of dermatologists, venereologists and leprologists (IADVL) task force against recalcitrant tinea (ITART) consensus on the management of glabrous …
Methods: Seventeen dermatologists with a focussed interest in dermatophytosis participated
in a Delphi consensus method, conducted in three rounds. They responded as either …
in a Delphi consensus method, conducted in three rounds. They responded as either …
Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis
Background: There has been an alarming increase in recalcitrant dermatophytosis in recent
years. The standard treatment guidelines no longer seem effective in achieving clearance …
years. The standard treatment guidelines no longer seem effective in achieving clearance …
Itraconazole pulse therapy for onychomycosis and dermatomycoses: an overview
P De Doncker, AK Gupta, G Marynissen… - Journal of the American …, 1997 - Elsevier
Background: Itraconazole is a broad-spectrum antifungal agent that has been used to treat
dermatomycosis and onychomycosis using continuous therapy. More recently the drug has …
dermatomycosis and onychomycosis using continuous therapy. More recently the drug has …
Treatment and prophylaxis of tinea infections
GE Piérard, JE Arrese, C Piérard-Franchimont - Drugs, 1996 - Springer
Superficial fungal infections affect millions of people throughout the world. Among them,
tinea represents cutaneous infections by dermatophytes. Therapeutic strategies depend …
tinea represents cutaneous infections by dermatophytes. Therapeutic strategies depend …
Itraconazole for the treatment of tinea pedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks.
AK Gupta, P Doncker, A Heremans, P Stoffels… - 1997 - cabidigitallibrary.org
The efficacy of itraconazole (400 mg/day) given for 1 week was compared with 100-200
mg/day administered for 2-4 weeks, in 484 patients with tinea pedis. Causative organisms …
mg/day administered for 2-4 weeks, in 484 patients with tinea pedis. Causative organisms …
The use of the new oral antifungal agents, itraconazole, terbinafine, and fluconazole to treat onychomycosis and other dermatomycoses
AK Gupta, D Albreski, JQ Del Rosso… - Current Problems in …, 2001 - Elsevier
Onychomycosis refers to a fungal infection of the nail bed and secondarily the nail plate.
This could be caused by dermatophytes, Candida species, and nondermatophyte molds …
This could be caused by dermatophytes, Candida species, and nondermatophyte molds …